Current knowledge in Polypodium leucotomos effect on skin protection
- 643 Downloads
This article provides an overview of pharmacology, toxicity, pharmacokinetics and clinical data of Polypodium leucotomos L. (PL). PL aerial part has proven to exert antioxidant, photoprotective and immunomodulatory activities; its mechanism of action is complex and includes several activities: (1) PL diminishes the production of reactive oxygen and nitrogen species (ROS, RNS); (2) PL inhibits the photoisomerization of trans-urocanic acid (t-UCA); (3) PL inhibits apoptosis induced by ultraviolet radiation; (4) PL prevents damage to genetic material and (5) PL enhances DNA repair. PL is not mutagenic and does not induce acute or chronic toxicity. Its biological effects have been proved in cell cultures, animal models, murine models and in human beings. Photoprotective activity has been assessed in healthy volunteers as well as in patients suffering from several cutaneous diseases such as vitiligo, psoriasis, idiopathic photodermatosis or melasma. PL results to be an efficient treatment especially for sensitive cutaneous phototypes and adds extra protection when ultraviolet radiation (UVR) exposure cannot be avoided, such as wide or narrow band UVB phototherapy or treatment with psoralens plus UVA exposure radiation.
KeywordsPolypodium leucotomos Photoprotection UV radiation Pharmacodynamics Clinical studies
The author thanks Dr. Eduardo Reyes for his assistance in the clinical data analysis.
- 8.De las Heras ME, Ledo E, Gonzalez S, Rocamora A, Ledo A (1997) An extract of Polypodium leucotomos (Difur) as an adyuvant to PUVA therapy. Med Cutan Iber 25:103–107Google Scholar
- 14.Gonzalez S, Alcaraz MV, Cuevas J, Pérez M, Jaén P, Alvarez-Mon M, Villarrubia VG (2000) An extract of the fern Polypodium leucotomos (Difur®) modulates Th1/Th2 cytokines balance in vitro and appears to exhibit anti-angiogenic activities in vivo: pathogenic relationships and therapeutic indications. Anticancer Res 20:1567–1576PubMedGoogle Scholar
- 18.Gonzalez S, Joshi PC, Pathak MA (1994) Polypodium leucotomos extract as an antioxidant agent in the therapy of skin disorders. J Invest Dermatol 102(4):651–659Google Scholar
- 19.Gonzalez S, Pathak MA, Cuevas J, Villarubia VG, Fitzpatrick TB (1997) Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psolaren-induced phototoxic reactions as well as depletion of Langerhans cells in human skin. Photodermatol Photoimmunol Photomed 13:50–60CrossRefPubMedGoogle Scholar
- 22.Hassler M, Swale B. (2001). Checklist of ferns and fern allies. Available at http://homepages.caverock.net.nz/~bj/fern/phlebodium.htm. Accessed 14 Jan 2014
- 24.Janczyk A, García-López MA, Fernández-Peñas P, Alonso-Lebrero JL, Benedicto I, López-Cabrera M, Gonzalez S (2007) A Polypodium leucotomos extract inhibits solar-simulated radiation-induced TF-α and iNOS expression, transcriptional activation and apoptosis. Experimental Dermatol 16:823–829CrossRefGoogle Scholar
- 25.Jiménez D, Naranjo R, Doblare E, Munoz C, Vargas JF (1987) Anapsos, an antipsoriatic drug in atopic dermatitis. Allergol Immunopathol (Madr) 15:185–189Google Scholar
- 37.Philips N, Smith J, Séller T, Gonzalez S (2003) Predominant effect of Polypodium leucotomos on membrane integrity, lipid peroxidation expression of elastin and matrixmetalloproteinase-1 in ultraviolet radiation exposed fibroblasts, and keratinocytes. J Dermatol Sci 32:1–9CrossRefPubMedGoogle Scholar
- 40.Reyes E, Vitale MA. (2013) Advances in photoprotection. Molecular mechanisms. Piel 28(4): 235–247. Available at http://dx.doi.org/10.1016/j.piel.2012.04.011
Related articles recently published in Archives of Dermatological Research (selected by the journal’s editorial staff)